Giorgos Bamias

25PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersMajor global burdens of diseaseInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Apr 27, 2026
Predictors of Response to Induction Therapy with Ustekinumab in Patients with Ulcerative Colitis: Results from a National Study in Greece.

|Oct 28, 2025
Incidence and Prognostic Factors for Colectomy in Acute Severe Ulcerative Colitis with Concomitant CMV Infection.

Konstantina Kitsou, Konstantina Chalakatevaki, Georgios Kokkotis

|Oct 13, 2025
Disease Monitoring in Inflammatory Bowel Disease Daily Clinical Practice and Impact on Treatment Decision Making: Real World Evidence From the Inflammatory Bowel Disease-PODCAST Study.

Axel Dignass, Fernando Magro, Ferdinando D'Amico

|May 11, 2025
Past But Not Forgotten: Innate Factors Affect the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease.

Georgios Kokkotis, Giorgos Bamias

|Feb 26, 2025
Temporal Trends in the Use of Biological Agents in Patients with Inflammatory Bowel Disease: Real-World Data from a Tertiary Inflammatory Bowel Disease Greek Center During a 5-Year Period.

Panagiotis Markopoulos, Aikaterini Gaki, Georgios Kokkotis

|Sep 25, 2024
Targeting the Sphingosine-1-Phosphate Pathway: New Opportunities in Inflammatory Bowel Disease Management.

Konstantina Kitsou, Georgios Kokkotis, Jesús Rivera-Nieves

Pageof 5

Frequent Collaborators

3 joint publications

Gerassimos J Mantzaris

2 joint publications

Spyridon Michopoulos

2 joint publications

Ioannis Drygiannakis

2 joint publications

Panagiotis Markopoulos